Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 84 (1) , 49-53
- https://doi.org/10.1016/0021-9150(90)90007-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemiaAtherosclerosis, 1985
- A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its applicationClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemiaAtherosclerosis, 1985
- A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.Journal of Lipid Research, 1984
- Influence of probucol on cholesterol and lipoprotein metabolism in man.Journal of Lipid Research, 1984
- Effects of probucol on homozygous cases of familial hypercholesterolemiaAtherosclerosis, 1983
- The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemiaAtherosclerosis, 1982
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981
- Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemiaMetabolism, 1980
- Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by achilles' tendon thicknessAtherosclerosis, 1977